Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.460
+0.020 (0.82%)
Nov 25, 2025, 4:00 PM EST - Market closed
Cronos Group Revenue
Cronos Group had revenue of $36.34M in the quarter ending September 30, 2025, with 6.06% growth. This brings the company's revenue in the last twelve months to $132.36M, up 19.00% year-over-year. In the year 2024, Cronos Group had annual revenue of $117.62M with 34.82% growth.
Revenue (ttm)
$132.36M
Revenue Growth
+19.00%
P/S Ratio
7.09
Revenue / Employee
$288,359
Employees
459
Market Cap
938.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
| Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
| Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
| Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
| Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CRON News
- 10 days ago - Investing in Cannabis: Three Leading Stocks to Watch This November - MarijuanaStocks
- 11 days ago - 3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026 - MarijuanaStocks
- 11 days ago - 4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill - Benzinga
- 12 days ago - Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling - CNBC
- 19 days ago - Cronos Group Inc. (CRON:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Top Canadian Cannabis Stocks to Watch in November 2025 - MarijuanaStocks
- 24 days ago - 'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance - CNBC
- 4 weeks ago - Cannabis Investing 2025: 3 Pot Stocks to Watch Before November - MarijuanaStocks